Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system
Frontiers in Pharmacology · 03.07.2025 · 16
DOI: 10.3389/fphar.2025.1538680 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.07.2025. Verfasst von Yongqi Qian und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adenosine serves a variety of biological purposes in the circulatory system and was first discovered in the heart in 1929. By interacting with four adenosine receptor (AR) subtypes of G protein-coupled receptors—A 1 AR, A 2a AR, A 2b AR, and A 3 AR—adenosine controls physiological processes. In pathological situations, spikes in adenosine activate the four receptor subtypes and alter downstream pathways by altering the generation of cyclic adenosine monophosphate, which contributes to autophagy and inflammation. There will inevitably be conflicting reactions from the various subtypes in this situation. Additionally, via mediating distinct signals or under various models and pathophysiological situations, the same subtype itself may have contradictory effects. Taken together, ARs’ conflicting regulatory roles in the cardiovascular system not only highlight the intricacy of their physiological roles but also offer a crucial avenue for future study into the treatment of cardiovascular diseases. The contradictory regulatory roles of adenosine and ARs in cardiovascular disorders, as well as their potential as therapeutic targets, are methodically outlined in this review.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- The Third People's Hospital of Chengdu, Clinical College of Southwest Jiao Tong University, Chengdu, China.
- Institute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zitieren
APA
Qian, Y., Zheng, Y., Leng, L., Liu, Q., Tian, X., Chen, S., Zhang, S., & Xie, J. (2025). Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1538680
Vancouver
Qian Y, Zheng Y, Leng L, Liu Q, Tian X, Chen S, et al. Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1538680
BibTeX
@article{Qian2025,
author = {Qian, Yongqi and Zheng, Yixuan and Leng, Liang and Liu, Qingqing and Tian, Xiaojuan and Chen, Shilin and Zhang, Sanyin and Xie, Jiang},
title = {Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1538680}
}
EUVIMED